Clinical Trial Update: Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer [Phase 3]

View source ↗

Summary

Phase 3 results from a trial comparing enfortumab vedotin plus pembrolizumab versus chemotherapy in untreated locally advanced or metastatic urothelial cancer h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Padcev (enfortumab vedotin)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Urothelial Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-09-27